Newsroom

News

With their project Vaccine for Prevention and Treatment of Trypanosoma cruzi Infection (CRUZIVAX), a consortium of eleven partners coordinated by the Helmholtz Centre for Infection Research has been awarded funding through the European Commission’s Horizon 2020 work programme. The aim of this project is to develop a highly effective, low-cost and easy to administer prophylactic vaccine candidate for Chagas disease, which is caused by the parasite Trypanosoma cruzi (T. cruzi). The vaccine is to be applied as a nasal spray. The project is coordinated by the Vaccinology department of the Helmholtz Centre for Infection Research (HZI) in Braunschweig under the direction of Prof Carlos A. Guzmán. The total funding amounts to more than eight million euros over a period of five years, about two million euros being provided to the HZI.

25.07.2019

HZI Campus

News

In the 1950s, researchers discovered bottromycins – natural substances produced by bacteria with antibiotic activity. Since these substances even kill human pathogens such as the hospital germ MRSA (methicillin-resistant Staphylococcus areus), they are of interest for drug development. After the discovery of bottromycins, it took until 2012 before researchers from the Helmholtz Centre for Infection Research (HZI) and its Saarbrücken location, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were able to identify the genes that bacteria need to form bottromycins. Now they were able to further unravel the underlying reactions in the bacterial cells.

20.06.2019

HIPS

News

As part of the “Big Data in den Lebenswissenschaften der Zukunft” (“Big data in the life sciences of the future”) call, the Lower Saxony Ministry of Science and Culture and the Volkswagen Foundation are supporting 16 innovative projects that are focused on the opportunities offered by data-intensive research and personalised medicine. The life sciences are currently among the most dynamic research fields in science – as shown by the fact that 54 applications were submitted. Funding will be provided for research projects that make particular use of the opportunities and possibilities resulting from the ongoing digitalisation of life sciences for the advancement of knowledge. These projects develop milestones for the transfer of newly acquired knowledge and implement its initial steps. A total of five projects involving the Helmholtz Centre for Infection Research (HZI) have received funding.

18.06.2019

HZI Campus

TWINCORE

CiiM

News

Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) veranstaltet am 27. und 28. Juni 2019 zum neunten Mal das HIPS-Symposium, bei dem führende Wissenschaftler der internationalen Wirkstoff-Forschung sowie pharmazeutische Nachwuchswissenschaftler ihre Ergebnisse vorstellen. In diesem Jahr wird zudem das zehnjährige Jubiläum des Saarbrücker Standortes des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig gefeiert. Die Festveranstaltung beginnt am 27. Juni um 9 Uhr in der Aula der Universität des Saarlandes (Gebäude A3 3).

13.06.2019

HIPS

News

On her visit to Saarland on 11 June, 2019, the Federal Minister of Education and Research Anja Karliczek informed herself about the current profile and areas of research at the Saarland University, and in particular about the further development of the scientific focus of NanoBioMed with special involvement of the HIPS. She spoke with the director of the institute, Prof Rolf Müller, and the president of the university, Prof Manfred Schmitt, and the Prime Minister of Saarland, Tobias Hans, about specific options for the future development of the HIPS and Saarland University in the field of pharmaceutical drug research. The current challenges facing infection research were a particular focus. The HIPS is a branch of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, operated in close collaboration with Saarland University.

11.06.2019

HIPS

News

The focus will be on the well-being of patients and protection of their privacy. The new Helmholtz Medical Security, Privacy and AI Research Center (HMSP) brings together researchers from the fields of IT security, data protection, artificial intelligence and medicine. Together they will develop solutions for individualised medicine, among other projects.

23.05.2019

HZI Campus

Back to the first page
...
77
78
79
80
...
155

HZI in the media

... sich auch das Helmholtz-Institut für Pharmazeutische Forschung Saarland ( HIPS ), das Helmholtz-Zentrum für Infektionsforschung ( HZI ) ...

09.04.2026

Deutsches Ärzteblatt

... ÖAW in Wien und nun Gruppenleiter am Helmholtz Zentrum für Infektionsforschung in Braunschweig, forscht an ...

08.04.2026

DerStandard.de

... group within the Microstar Program at the Helmholtz Centre for Infection Research (HZI) and a ...

31.03.2026

Informations Dienst Wissenschaft

... an der Medizinischen Hochschule Hannover und am Helmholtz Institut für Infektionen in Braunschweig die Wirkung ...

28.03.2026

Hamburger Abendblatt

led by wildlife veterinarian Fabian Leendertz, who heads the Helmholtz Institute for One Health, took hundreds of samples from meat and

27.03.2026

Science.org

Gesellschaft. Apropos Standort Braunschweig: Auch das Helmholtz-Zentrum für Infektionsforschung HZI, in dessen Räumlichkeiten auf dem ...

27.03.2026

transkript

Helmholtz Centre for Infection Research

After infection with SARS-CoV-2, up to 10 percent of people in Germany go on to develop Long COVID.

26.03.2026

Mirage.News

... von verschiedenen Hörnchen, wie jüngste Erkenntnisse des Helmholtz Instituts für One Health in Greifswald kürzlich ...

26.03.2026

Tagesschau

zur Bekämpfung der Tuberkulose und des Helmholtz-Zentrums für Infektionsforschung erstellt. Zahlreiche weitere Fachgesellschaften und

24.03.2026

Deutsches Ärzteblatt

... fünf Teams durch, darunter PROTON vom Helmholtz-Zentrum für Infektionsforschung. Dieses entwickelt einen neuartigen Wirkstoff gegen ...

22.03.2026

Ad Hoc News

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.